📋 Tender Overview
Bacteriocins From Interbacterial Warfare As Antibiotic Alternative
Bacterial Peptides As Novel Antimicrobial Agentsthe Ability Of Microorganisms To Withstand Treatment With Antimicrobial Agents Is Known As Antimicrobial Resistance (Amr) And Poses A Significant Health Threat. Given The Absence Of New Drugs In The Pharmaceutical Pipeline, Amr Threatens The Outcome Of Medical Treatments. Funded By The European Research Council, The Bacthewinner Project Focuses On Bacteriocins, Small Antibacterial Peptides Encoded By The Bacterial Genome, As Novel Antimicrobial Agents. Bacteriocins May Have A Narrow Or Broad Inhibition Spectrum And Can Be Improved By Molecular Genetics Including Peptide Engineering. The Project Will Pave The Way For The Generation Of A New Family Of Therapeutics Against Dangerous Resistant Pathogens.
Funded Under
European Research Council (Erc)
Total Cost
€ 2 500 000,00
Eu Contribution
€ 2 500 000,00
Coordinated By
University College Cork - National University Of Ireland, Cork
Ireland
